As of Aug 19 2014 4:00PM
Minimum 20 minute delay
  • 8/18/2014 4:05:00 PM

    Study Published in JACC CI Demonstrates Directional Atherectomy Effective as Frontline Therapy for Peripheral Arterial Disease Patients

    Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and claudicant patients DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 18, 2014-- Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark …
  • 7/25/2014 6:00:00 AM

    Covidien Reports Third-Quarter Fiscal 2014 Results

    Net sales up 4%; Medical Devices sales up 5% Third-quarter diluted GAAP earnings per share were $0.67; excluding specified items, adjusted diluted earnings per share were $1.04, up 14% DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 25, 2014-- …
  • 7/22/2014 7:01:00 AM

    Covidien Announces Leadership Appointment

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014-- Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien, effective Oct. 1…

A Partner in Health

Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.

Conscientious Collaboration

Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.

One Covidien

One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.

Visit Us